Gastrointestinal stromal tumors: Clinical and pathological analysis of 24 cases

Revista de Investigacion Clinica

Volumn 56, Issue 4, 2004, Pages 443-448

  Zepeda Gomez, Sergio ^a   Nuncio, Juan F ^a   Maldonado, Héctor ^a   Arista Nasr, Julian ^a   Sánchez, Eduardo ^a   Schmulson, Max ^a   Uscanga Domínguez, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

c Kit protein; Gastrointestinal stromal tumor; GIST; Leiomyosarcoma

Indexed keywords

DOXORUBICIN; FLUOROURACIL; STEM CELL FACTOR RECEPTOR; VINCRISTINE;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LIVER METASTASIS; MALE; MUSCLE TUMOR; NEURILEMOMA; PANCREATICODUODENECTOMY; PERITONEUM METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SMALL INTESTINE TUMOR; STOMACH ANTRUM RESECTION; STOMACH TUMOR; TOTAL STOMACH RESECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED;

EID: 7444270693     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 1996; 13: 297-313.
2. Berman J, O'Leary T. Gastrointestinal Stromal Tumor Workshop. Hum Pathol 2001; 32: 578-82.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-20.
4. Strickland L, Letson D, Muro-Cacho C. Gastrointestinal stromal tumors. Cancer Control 2001; 8: 252-61.
5. Joensuu H, Roberts P, Sarlomo-Rikala M, Andersson L, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-6.
6. Tuveson DA, Willis NA, Jacks T, Griffin JD, Singer S, Fletcher CD, et al. STI571 inactivation of the gastrointestinal stromal tumor c-kit oncoprotein: biological and clinical implications. Oncogene 2001; 20: 5054-8.
7. Van Oostrom AT, Judson I, Verweij J, Stroobants S, Donato Di Paola E, Dimitijevic S, et al. European Organization for Research and Treatment of Cancer Soft tissue and Bone Sarcoma group. Safety and efficacy of Imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001; 358: 1421-3.
8. Brooks BJ, Bani JC, Fletcher CD, Demeteri GD. Response of metastatic gastrointestinal stromal tumor including CNS involvement to imatinib mesylate (STI571). J Clin Oncol 2002; 20: 870-2.
9. Sakurai S, Fukasawa T, Chong JM. C-kit gene abnormalities in gastrointestinal stromal tumors. Jpn J Cancer Res. 1999; 90: 1321-8.
10. Seidal T, Edvardsson H. Expression of c-Kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors. Histopathology. 1999; 34: 416-24.
11. Sarlomo-Rikala M, Kovatich A, Barusevicius A. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11: 728-34.
12. Hou Y, Wang J, Zhu X, Du X, Sun M, Zheng A. A clinicopathological and immunohistochemical study on 76 cases of gastrointestinal stromal tumors. Chinese J Pathol 2002; 31: 20-5.
13. Kim C, Day S, Yeh K. Gastrointestinal stromal tumors: analysis of clinical and pathologic factors. Am Surg 2001; 67: 135-7.
14. Ueyama T, Guo K, Hashimoto H, Daimaru H, Enjoji M. A clinicopathological and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992; 69: 947-55.
15. Goldblum J, Appelman H. Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 1995;19: 71-80.
16. Emory T, Sobin I, Lukes L. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Am J Surg Pathol 1999; 23: 82-7.
17. Perego M, Strada E, Alvisi C, Ascari E. Gastrointestinal stromal tumors as the cause of intestinal hemorrhage: description of a clinical case. Annali Italiani di Medicina Interna 1998; 13: 125-7.
18. Treska V, Ludvikova M, Simanek V. Stromal tumor of the small intestine - a cause of massive gastrointestinal hemorrhage. Rozhledy V Chirurgii 2001; 80: 121-3.
19. Ruiz AR. Multiple malignant gastrointestinal stromal tumors presenting with GI bleeding: a case report and a review of the literature. Gastrointest Endosc 2000; 51: 225-8.
20. Pieri JP, Choudry U, Muzikansky A, Yeap BY, Souba W, Ott MJ. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch of Surgery 2001; 136: 383-9.
21. Crosby JA, Catton CN, Davis A, Couture J, O'Sullivan B, Kandell R, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001; 8: 50-9.
22. D'Amato A, Brini A, Montesani C, Pronio A, Chessa A, Manzi F, et al. Gastrointestinal stromal tumors: a series of 23 surgically treated cases. Annali Italiani di Chirurgia 2001; 72: 175-80
23. Demetri G, von Mehren M, Blanke C, Van den Abbeele, A, Eisenberg B, Roberts P, et al. Efficacy and safety of Imatinib Mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002; 347: 472-80
24. Blanke DC, von Mehren M, Joensuu H, et al. Evaluation and safety and efficacy of an oral molecularly targeted therapy, STI571, in patients with unresectable or metastatic, gastrointestinal stromal tumors expressing c-kit (CD117). Proc Annu Meet Am Soc Clin Oncol 2001; 20. Abstract 1.